156 related articles for article (PubMed ID: 7893482)
1. Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations.
Riccio A; Reynaud L; Postiglione L; Catalano M; Natale D; Pronestì G; Melfa V; Cicciarello S; Borgia G
Boll Soc Ital Biol Sper; 1994; 70(8-9):235-42. PubMed ID: 7893482
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
5. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
6. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
8. Humoral immunity in Nigerians with Schistosoma haematobium infection.
Arinola OG; Salimonu LS
West Afr J Med; 1999; 18(4):275-80. PubMed ID: 10734791
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
[TBL] [Abstract][Full Text] [Related]
10. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
11. [The significance of multiple infections with HBV, HCV and HDV in patients with chronic liver diseases].
Zhang X
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):212-6. PubMed ID: 8143320
[TBL] [Abstract][Full Text] [Related]
12. Immunological studies in HBV-related chronic liver diseases.
Joshi N; Ayesha Q; Habibullah CM
Indian J Pathol Microbiol; 1990 Oct; 33(4):351-4. PubMed ID: 2132503
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis with hepatitis delta virus infection.
Tsai JF; Margolis HS; Fields HA; Nainan OV; Chang WY; Tsai JH
J Med Virol; 1990 Jan; 30(1):25-9. PubMed ID: 2303803
[TBL] [Abstract][Full Text] [Related]
14. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
15. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
[TBL] [Abstract][Full Text] [Related]
16. [Immunological features of rheumatoid arthritis in patients infected with viruses of hepatitis B, C and in patients with cryoglobulinemia].
Balabanova RM; Shekshina EV; Kozlov LV
Ter Arkh; 2004; 76(11):74-7. PubMed ID: 15658544
[TBL] [Abstract][Full Text] [Related]
17. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
[TBL] [Abstract][Full Text] [Related]
18. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
20. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]